SMTL ID : 4tpk.1 (1 other biounit)

Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-methoxyethyl)-2-naphthamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUL.1: 4 residues within 4Å: Chain A: R.42, D.82, I.83, N.85 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.83

3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 4 residues within 4Å: Chain A: K.133, N.134, N.216, K.218 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 5 residues within 4Å: Chain A: Y.505, N.509, E.510, T.511, Q.512 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 1 residues within 4Å: Chain A: N.514 No protein-ligand interaction detected (PLIP)

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.3: 4 residues within 4Å: Chain A: N.269, N.273, K.276, F.306 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.273, A:F.306 Hydrophobic interactions: A:N.273, A:K.276

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG-FUC.4: 6 residues within 4Å: Chain A: A.362, P.363, G.364, S.366, N.369, I.372 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:A.362, A:G.364

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.7: 2 residues within 4Å: Chain A: N.45, T.52 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.52

1 x 3F9: N-{[(3R)-1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl]methyl}-N-(2-methoxyethyl)naphthalene-2-carboxamide(Non-covalent)

3F9.8: 16 residues within 4Å: Chain A: N.96, I.97, D.98, W.110, G.144, G.145, T.148, E.225, S.226, W.259, A.356, F.357, Y.360, F.426, H.466, G.467 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:D.98, A:T.148, A:F.357, A:Y.360, A:Y.360, A:F.426 Salt bridges: A:D.98 pi-Stacking: A:W.259, A:W.259, A:F.357

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.9: 5 residues within 4Å: Chain A: N.256, C.428, P.429, E.432, T.551 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.256, A:C.428

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.10: 3 residues within 4Å: Chain A: H.105, M.109, E.471 No protein-ligand interaction detected (PLIP) EDO.11: 4 residues within 4Å: Chain A: L.46, W.126, D.157, K.159 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.89, A:W.126, A:K.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brus, B. et al., Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. J.Med.Chem. (2014)

Release Date

2014-10-22

Peptides

Cholinesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholinesterase

Related Entries With Identical Sequence